Discover
CUE
Cue Biopharma, Inc.
20.87
2 x 14.71
2 x 25.90
bid
ask
-
0.58
2.70%
2 @ 04:00 PM
20.87 +0.00 (0.00%)
| Ytd | 128.09% | |
| 1y | -0.48% |
19.85
day range
21.16
4.98
52 week range
45.50
| Open | 20.66 | Prev Close | 21.45 | Low | 19.85 | High | 21.16 | Mkt Cap | 151.61M |
| Vol | 60.77K | Avg Vol | 267.08K | EPS | -29.59 | P/E | N/A | Forward P/E | -1.79 |
| Beta | 1.80 | Short Ratio | 1.54 | Inst. Own | 23.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 25.60 | 200-d Avg | 21.10 | 1yr Est | 3.60 |
| Income Statement | |||
| Total Revenue | 7.88M | ||
| Revenues (USD) | 7.88M | ||
| Gross Profit | 7.88M | ||
| Operating Expenses | 95.57M | ||
| Research and Development Expense | 49.01M | ||
| Selling, General and Administrative Expense | 46.57M | ||
| Operating Income | -87.69M | ||
| Interest Expense | 5.00K | ||
| Net Income | -153.07M | ||
| Net Income Common Stock | -153.07M | ||
| Net Income Common Stock (USD) | -153.07M | ||
| Consolidated Income | -153.07M | ||
| Earnings per Basic Share | -24.14 | ||
| Earnings per Basic Share (USD) | -24.14 | ||
| Earnings per Diluted Share | -24.14 | ||
| Earning Before Interest & Taxes (EBIT) | -153.06M | ||
| Earning Before Interest & Taxes (USD) | -153.06M | ||
| Weighted Average Shares | 6.34M | ||
| Weighted Average Shares Diluted | 6.34M | ||
| Balance Sheet | |||
| Cash and Equivalents | 18.17M | ||
| Cash and Equivalents (USD) | 18.17M | ||
| Trade and Non-Trade Receivables | 5.38M | ||
| Current Assets | 26.62M | ||
| Property, Plant & Equipment Net | 3.21M | ||
| Total Assets | 30.71M | ||
| Debt Current | 1.63M | ||
| Total Debt | 3.08M | ||
| Current Liabilities | 21.22M | ||
| Debt Non-Current | 1.45M | ||
| Total Liabilities | 28.40M | ||
| Accumulated Retained Earnings (Deficit) | -526.71M | ||
| Shareholders Equity | 2.31M | ||
| Shareholders Equity (USD) | 2.31M | ||
| Assets Non-Current | 4.08M | ||
| Total Debt (USD) | 3.08M | ||
| Liabilities Non-Current | 7.18M | ||
| Trade and Non-Trade Payables | 4.71M | ||
| Tax Assets | 1.90M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 408.00K | ||
| Net Cash Flow from Financing | 30.02M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.01M | ||
| Issuance (Purchase) of Equity Shares | 30.02M | ||
| Net Cash Flow from Operations | -29.00M | ||
| Share Based Compensation | 23.84M | ||